Pharmafile Logo
Pharmafocus logo
Advanced Search

clinical trial

Showing 15 posts of 189 posts found.

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024
Research and Development CIDP, Hyqvia, Neurology, Takeda, clinical trial

Takeda has announced data from the phase 3 ADVANCE-CIDP 3 trial, which assessed the safety and efficacy of Hyqvia (Immune …

News

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

June 19, 2024
Research and Development Assembly Biosciences, Hepatology, clinical trial, hepatitis

Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s …

News

Innate Pharma shares results from phase 1/2 trial for blood cancer treatment

June 17, 2024
Research and Development Innate Pharma, Oncology, blood cancer, clinical trial

Innate Pharma has announced updated efficacy and safety results from the dose-escalation part of the phase 1/2 study with SAR443579/IPH6101 …

News

Cara Therapeutics shares data from part a of notalgia paresthetica trial

June 13, 2024
Research and Development Cara Therapeutics, Neurology, clinical trial, notalgia paresthetica, pruritus

Cara Therapeutics has announced the outcome from the dose-finding Part A of the KOURAGE-1 study which assessed the efficacy and …

News

Tracon shares data from phase 2 trial for glioblastoma treatment

June 12, 2024
Medical Communications Oncology, Tracon Pharmaceuticals, clinical tria, clinical trial, glioblastoma

Tracon Pharmaceuticals has announced the publication of its phase 2 clinical data for its DNA damage repair inhibitor drug candidate, …

News

Eli Lilly shares results for tirzepatide for MASH resolution

June 10, 2024
Research and Development Eli Lilly, Hepatology, MASH, clinical trial, liver

Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, with or without type 2 …

News

AbbVie initiates phase 3 multiple myeloma trial

June 6, 2024
Medical Communications ABBV-383, AbbVie, Oncology, clinical trial, multiple myeloma

AbbVie has announced that it has dosed the first patient in its phase 3 CERVINO trial, which aims to assess …

News
testalize-me-0je8ynv4mis-unsplash

Sanofi shares phase 3 trial results for Sarclisa in multiple myeloma treatment

June 5, 2024
Research and Development Oncology, Sanofi, Sarclisa, clinical trial, multiple myeloma

Sanofi has announced data from the IMROZ phase 3 trial which assessed Sarclisa (isatuximab) in combination with standard-of-care bortezomib, lenalidomide …

News

Oryzon Genomics announces publication of phase 2a ALICE trial results

June 4, 2024
Medical Communications AML, Oncology, Oryzon genomics, acute myeloid leukaemia, clinical trial

Oryzon Genomics has announced that the final results from its phase 2a ALICE study have been published online in The …

News

Gilead and Arcus announce results from colorectal cancer treatment trial

June 3, 2024
Research and Development Arcus, Gilead, Oncology, clinical trial, colorectal cancer

Gilead Sciences and Arcus Biosciences have announced new data from cohort B of ARC-9, a phase 1b/2 study which aims …

News

Merck shares data from phase 3 trial of Keytruda for TNBC treatment

May 29, 2024
Medical Communications Merck, Oncology, breast cancer, clinical trial, keytruda

Merck, known as MSD outside of the US and Canada, has announced results from the phase 3 KEYNOTE-522 trial, which …

News

AstraZeneca shares results from phase 3 TROPION-Lung01 trial

May 28, 2024
Medical Communications AstraZeneca, Daiichi Sankyo, NSCLC, Oncology, clinical trial, datopotamab deruxtecan

AstraZeneca has announced results from the phase 3 TROPION-Lung01 trial of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd). The survival …

News

Eli Lilly shares positive results from phase 3 VIVID-1 trial of Crohn’s disease treatment

May 22, 2024
Medical Communications Crohn’s disease, Eli Lilly, Endocrinology, clinical trial, mirikizumab

Eli Lilly has announced results from its pivotal phase 3 VIVID-1 study, which assessed patients with moderately to severely active …

News

GSK shares positive results from phase 3 asthma trials

May 21, 2024
Research and Development Asthma & COPD, GSK, asthma, clinical trial

GSK has announced positive headline results from its phase 3 SWIFT-1 and SWIFT-2 trials, which evaluated the safety and efficacy …

News

J&J’s Tremfya meets primary and secondary endpoints in UC maintenance study

May 21, 2024
Medical Communications Gastrointestinal tract, J&J, Johnson & Johnson, clinical trial, ulcerative colitis

Johnson & Johnson (J&J) has announced the first data from its phase 3 QUASAR maintenance study which assessed Tremfya (guselkumab) …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026